<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Quinoline based mono- and bis-(thio) carbohydrazones: synthesis, anticancer activity in 2D and 3D cancer and cancer stem cell models

dc.contributor.authorBozic, Aleksandra
dc.contributor.authorMarinkovic, Aleksandar
dc.contributor.authorBjelogrlic, Snezana
dc.contributor.authorTodorovic, Tamara R.
dc.contributor.authorCvijetic, Ilija N.
dc.contributor.authorNovakovic, Irena
dc.contributor.authorMuller, Christian D.
dc.contributor.authorFilipovic, Nenad R.
dc.date.accessioned2026-11-05T11:00:08Z
dc.date.issued2016
dc.description.abstractA comparative study of antitumor activity of mono- and bis-quinoline based (thio) carbohydrazones was investigated by a series of tests on two human malignant cell lines: acute monocytic leukemia (THP-1) and pancreatic adenocarcinoma cancer stem cells (AsPC-1). Thiocarbohydrazones (TCHs) revealed superior pro-apoptotic activity over carbohydrazones (CHs) on both tested cell phenotypes, also displaying multi-target profile activities. Programmed cell death triggered by TCHs was partially caspase-dependent, mainly caspase-8 related. Activity against cancer stem cells (CSCs) was evaluated on 2D monolayers and 3D spheroidal models, where two out of three tested bis-TCHs successfully stimulated apoptosis accompanied by a reduction in size of treated spheres. Additionally, all bis-TCHs induced significant decrease in percentage of CD44-expressing AsPC-1 cells that indicate on their ability to induce reprogramming of CSC phenotype. Current results highly support further assessment of bis-TCHs in order to specify their specific targets in cancer cells and particularly in the CSCs subpopulation.
dc.description.issue106
dc.description.pages104763-104781
dc.description.sponsorshipThe authors acknowledge networking support by the COST Action CM1106 StemChem - Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells. The work was funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grants 172055 and 172013).
dc.description.volume6
dc.identifier.doi10.1039/c6ra23940d
dc.identifier.issn2046-2069
dc.identifier.urihttps://doi.org/10.1039/c6ra23940d
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10349
dc.identifier.wosWOS:000388111900107
dc.language.isoen
dc.publisherROYAL SOC CHEMISTRY
dc.relation.fundingCOST Action CM1106 StemChem - Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells
dc.relation.fundingMinistry of Education, Science and Technological Development of the Republic of Serbia
dc.relation.fundingMinistry of Education, Science and Technological Development of the Republic of Serbia [172055, 172013]
dc.relation.hasversion10.1039/c6ra23940d
dc.relation.ispartofRSC ADVANCES
dc.subjectBIOLOGICAL-ACTIVITIES
dc.subjectMETAL-COMPLEXES
dc.subjectDRUG DISCOVERY
dc.subjectSERUM-ALBUMIN
dc.subjectIN-VITRO
dc.subjectTHIOSEMICARBAZONES
dc.subjectDERIVATIVES
dc.subjectREDUCTASE
dc.subjectANTITUMOR
dc.subjectTRIAPINE
dc.subjectChemistry, Multidisciplinary
dc.subjectChemistry
dc.titleQuinoline based mono- and bis-(thio) carbohydrazones: synthesis, anticancer activity in 2D and 3D cancer and cancer stem cell models
dc.typeArticle
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.endPage104781
oaire.citation.issue106
oaire.citation.startPage104763
oaire.citation.volume6
person.identifier.orcid0000-0001-9881-1204
person.identifier.orcid0000-0002-1910-4729
person.identifier.orcid0000-0003-2982-5324
person.identifier.orcid0000-0002-5568-6172
person.identifier.orcid0000-0002-6790-0287
person.identifier.orcid0000-0002-7740-3639
person.identifier.orcid0000-0003-3239-5476
person.identifier.orcid0000-0002-3463-1025
person.identifier.ridG-3418-2012
person.identifier.ridB-5402-2018
person.identifier.ridAAF-3199-2020
person.identifier.ridP-8803-2016
person.identifier.ridF-8399-2010

Files

Collections